PET imaging of early stages of Alzheimer's disease (AD) in transgenic mice with F-18 hydroxy quinoline

被引:0
|
作者
Kulkarni, Padmakar [1 ]
Arora, Veera [1 ]
Chiguru, S. [1 ]
Hao, Guiyang [1 ]
Gupta, A. [1 ]
Slavine, Nikolai [1 ]
Vasdev, Neil [2 ]
Sun, Xiankai [1 ]
Antich, P. [1 ]
Bonte, Frederick [1 ]
机构
[1] UT Southwestern Med Ctr, Radiol, Dallas, TX USA
[2] Univ Toronto, Psychiat, CAMH, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1176
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Development of 18F-Labeled PET Probes for Imaging Neuropathology of Alzheimer's Disease
    Furumoto, Shozo
    Okamura, Nobuyuki
    Higuchi, Makoto
    Iwata, Ren
    Kudo, Yukitsuka
    Yanai, Kazuhiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 252P - 252P
  • [32] 18F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer's Disease: A Miniperspective
    Kung, Hank F.
    Choi, Seok Rye
    Qu, Wenchao
    Zhang, Wei
    Skovronsky, Daniel
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 933 - 941
  • [33] Impact of F-18 FDG PET/CT imaging of Carney's triad
    Ba Nguyen
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [34] Plaque and tangle brain imaging using [F-18]FDDNP PET differentiates Alzheimer's disease, mild cognitive impairment and older controls
    Small, G
    Kepe, V
    Huang, SC
    Ercoli, L
    Siddarth, P
    Miller, K
    Lavretsky, H
    Wright, BC
    Satyamurthy, N
    Wu, HH
    Shoghi-Jadid, K
    Petric, A
    Phelps, ME
    Barrio, JR
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S8 - S8
  • [35] IMAGING NEUROINFLAMMATION IN THE EARLY STAGE OF ALZHEIMER'S DISEASE: A PET STUDY USING [18F]DPA-714
    Leroy, C.
    Hamelin, L.
    Lagarde, J.
    Peyronneau, M. A.
    Corne, H.
    Labit, M.
    Gervais, P.
    Kuhnast, B.
    Oppenhein, C.
    Mangin, J. F.
    Sarazin, M.
    Bottlaender, M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 688 - 689
  • [36] PET imaging of cerebral nicotinic acetylcholine receptors (nAChRs) in early Alzheimer's disease (AD) assessed with the new radioligand (-)-[18F]-norchloro-fluoro-homoepibatidine ([18F]Flubatine)
    Sabri, Osama
    Wilke, Stephan
    Graef, Susanne
    Becker, Georg
    Hesse, Swen
    Schoenknecht, Peter
    Wagenknecht, Gudrun
    Hoepping, Alexander
    Steinbach, Joerg
    Brust, Peter
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S55 - S55
  • [37] Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer's Disease
    Kuntner, Claudia
    Kesner, Adam L.
    Bauer, Martin
    Kremslehner, Robert
    Wanek, Thomas
    Mandler, Markus
    Karch, Rudolf
    Stanek, Johann
    Wolf, Tanja
    Mueller, Markus
    Langer, Oliver
    MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (04) : 236 - 240
  • [38] Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease
    Claudia Kuntner
    Adam L. Kesner
    Martin Bauer
    Robert Kremslehner
    Thomas Wanek
    Markus Mandler
    Rudolf Karch
    Johann Stanek
    Tanja Wolf
    Markus Müller
    Oliver Langer
    Molecular Imaging and Biology, 2009, 11 : 236 - 240
  • [39] The Value of F-18 FDG PET/CT in the Management of Castleman' s Disease
    Fu, Zhanli
    Li, Wei
    Zhang, Jianhua
    Chen, Xueqi
    Li, Qian
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [40] [18F]AV-1451 PET imaging differentiates the tauopathies of Progressive Supranuclear Palsy (PSP) and Alzheimer's disease (AD)
    Rodriguez, P. Vazquez
    Passamonti, L.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 242 - 242